Keryx Biopharmaceuticals (KERX)' Zerenex (Ferric Citrate Coordination Complex) Data Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2013
10/17/2013 9:42:41 AM
NEW YORK, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that abstracts highlighting Zerenex™ (ferric citrate coordination complex), the Company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease (CKD) on dialysis, have been selected for oral and poster presentations during the American Society of Nephrology (ASN) Kidney Week 2013 annual meeting. This annual meeting of the ASN will be held in Atlanta, Georgia, from November 5-10, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by